Jugno, Paul H.

HRN: 18-41-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFUROXIME 750MG (VIAL)
10/18/2022
10/25/2022
IVTT
460mg
Q8h
Infectious Diarrhea
Waiting Final Action 
10/18/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/18/2022
10/25/2022
IVTT
150mg
Q8h
T/c Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: